TTK HEALTHCARE LTD.-$ - 507747 - The 64Th Annual General Meeting Of The Company Has Been Scheduled To Be Held On Wednesday, The 3Rd August, 2022, Through Video Conferencing / Other Audio Visual Means (VC / OAVM)
The 64th Annual General Meeting of the Company has been scheduled to be held on Wednesday, the 3rd August, 2022, through Video Conferencing / Other Audio Visual Means (VC / OAVM) TTK HEALTHCARE LTD.-$ - 507747 - Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today, inter alia considered and approved / recommended the following: (i) Dividend of Rs.10/- (100%) per Equity Share of Rs.10/- each, for the financial year ended 31st March, 2022 which shall be paid / despatched within 21 days from the date of AGM, subject to the approval of the Shareholders; (ii) The 64th Annual General Meeting of the Company has been scheduled to be held on Wednesday, the 3rd August, 2022, through Video Conferencing / Other Audio Visual Means (VC / OAVM); (iii) We enclose a brief highlights of the Audited Financial Statements (in Annexure-1). TTK HEALTHCARE LTD.-$ - 507747 - Audited Financial Results For The Fourth Quarter And Year Ended 31St March, 2022
Pursuant to the provisions of Regulations 30 & 33 of the SEBI (LODR) Regulations, 2015, we are sending herewith the following documents, duly approved and taken on record by the Board of Directors in their meeting held today [(i.e.) 23rd May, 2022]: (i) Audited Financial Results for the Fourth Quarter and Year ended 31st March, 2022; (ii) Statutory Auditors' Report with unmodified opinion; and (iii) Declaration by the Executive Vice Chairman (CEO) that the Audit Report is with unmodified opinion. TTK HEALTHCARE LTD.-$ - 507747 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Loss / Misplacement of Share Certificate and Receipt of Application for issuance of Duplicate Share Certificate TTK HEALTHCARE LTD.-$ - 507747 - Update On Sale / Transfer Of Human Pharma Division (Undertaking) Of The Company
With further reference to our Communication No.TTKH:SEC:GJ:037:22 dated 21st March, 2022, on the above subject, we wish to inform you that pursuant to the definitive agreements entered into on 21st March, 2022 and the approval of the Shareholders by means of a Special Resolution passed through Postal Ballot process, the Human Pharma Division (Undertaking) of the Company has been transferred to M/s BSV Pharma Private Limited, effective from this date (i.e.) 9th May, 2022. TTK HEALTHCARE LTD.-$ - 507747 - Minutes Of The Proceedings Held On 25Th April, 2022 For Declaration Of Results Of The Postal Ballot Process
Certified true copy of the Minutes of the proceedings held on Monday, the 25th April, 2022, for declaration of results of the Postal Ballot by way of remote e-Voting process for the Special Resolution deemed to have been passed by the Shareholders of the Company on Saturday, the 23rd April, 2022, being the last date of e-Voting. TTK HEALTHCARE LTD.-$ - 507747 - Board to consider Dividend
TTK Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 23, 2022, inter alia, 1. To consider and approve the Audited Financial Results of the Company for the year ended March 31, 2022; and2. To consider and recommend dividend, if any, for the linancial yeat 2021-22.Further, as informed vide the Company''s Communication dated March 31, 2022, pursuant to the amended SEBI (Prohibition of lnsider Trading) Regulations, 2015 and Company''s Code of Conduct for Prevention of lnsider Trading, the Trading Window fordealing in the shares by the Designated Persons of the Company and their immediate relatives, remains closed from April 01, 2022 to May 25, 2022 (both days inclusive). Accordingly, all the Designated Persons of the Company and their immediate relatives have been intimated not to trade in the Company''s shares during the aforesaid period of closure of Trading Window. TTK HEALTHCARE LTD.-$ - 507747 - Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors
TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2022 ,inter alia, to consider and approve the Audited Financial Results of the Company for the year ended 31st March, 2022 and dividend, if any, for the financial year 2021-22. TTK HEALTHCARE LTD.-$ - 507747 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company TTK HEALTHCARE LTD.- 2 CIN NO. L24231TN1958PLC003647 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 0 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)0 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-S KALYANARAMANDesignation :-WHOLETIME DIRECTOR AND SECRETARY Name of the Chief Financial Officer :- B V K DURGA PRASAD Designation : -PRESIDENT FINANCE Date: 28/04/2022